Cargando…

Evaluation of disseminated tumor cells and circulating tumor cells in patients with breast cancer receiving adjuvant zoledronic acid

We evaluated disseminated tumor cells (DTCs) and circulating tumor cells (CTCs) in patients with stage I-III breast cancer with >4 MM/mL DTC at baseline who received adjuvant zoledronic acid (ZOL). ZOL was administered every 4 weeks for 24 months, and patients underwent bone marrow aspiration at...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vidula, Neelima, Greenberg, Sally, Petrillo, Laura, Hwang, Jimmy, Melisko, Michelle, Goga, Andrei, Moasser, Mark, Magbanua, Mark, Park, John W., Rugo, Hope S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8421499/ https://www.ncbi.nlm.nih.gov/pubmed/34489453 http://dx.doi.org/10.1038/s41523-021-00323-8

Ejemplares similares

Approaches to isolation and molecular characterization of disseminated tumor cells
por: Magbanua, Mark Jesus M., et al.
Publicado: (2015)

Genomic and expression profiling reveal molecular heterogeneity of disseminated tumor cells in bone marrow of early breast cancer
por: Magbanua, Mark Jesus M., et al.
Publicado: (2018)

Androgen receptor gene expression in primary breast cancer
por: Vidula, Neelima, et al.
Publicado: (2019)

Exhausted T cell signature predicts immunotherapy response in ER-positive breast cancer
por: Terranova-Barberio, Manuela, et al.
Publicado: (2020)

Genome-wide copy number analysis of cerebrospinal fluid tumor cells and their corresponding archival primary tumors
por: Magbanua, Mark Jesus M., et al.
Publicado: (2014)

Amelioration of sexual adverse effects in the early breast cancer patient
por: Melisko, Michelle E., et al.
Publicado: (2010)

Influence of zoledronic acid on disseminated tumor cells in bone marrow and survival: results of a prospective clinical trial
por: Banys, Malgorzata, et al.
Publicado: (2013)

Adjuvant Zoledronic Acid in High‐Risk Giant Cell Tumor of Bone: A Multicenter Randomized Phase II Trial
por: Lipplaa, Astrid, et al.
Publicado: (2019)

Immunotherapy in Breast Cancer and the Potential Role of Liquid Biopsy
por: Magbanua, Mark Jesus M., et al.
Publicado: (2022)

Serial expression analysis of breast tumors during neoadjuvant chemotherapy reveals changes in cell cycle and immune pathways associated with recurrence and response
por: Magbanua, Mark Jesus M., et al.
Publicado: (2015)

A phase II study of the histone deacetylase inhibitor vorinostat combined with tamoxifen for the treatment of patients with hormone therapy-resistant breast cancer
por: Munster, P N, et al.
Publicado: (2011)

Zoledronic acid alters hematopoiesis and generates breast tumor-suppressive bone marrow cells
por: Ubellacker, Jessalyn M., et al.
Publicado: (2017)

Combination of Melatonin and Zoledronic Acid Suppressed the Giant Cell Tumor of Bone in vitro and in vivo
por: Wang, Xudong, et al.
Publicado: (2021)

Scalp cooling with adjuvant/neoadjuvant chemotherapy for breast cancer and the risk of scalp metastases: systematic review and meta-analysis
por: Rugo, Hope S., et al.
Publicado: (2017)

Next-Generation Sequencing of Disseminated Tumor Cells
por: Møller, Elen K., et al.
Publicado: (2013)

Immune Responses against Disseminated Tumor Cells
por: Peng, Ling, et al.
Publicado: (2021)

Dosing of zoledronic acid with its anti-tumor effects in breast cancer
por: Zhao, Xinmin, et al.
Publicado: (2015)

A Novel Strategy for Detection and Enumeration of Circulating Rare Cell Populations in Metastatic Cancer Patients Using Automated Microfluidic Filtration and Multiplex Immunoassay
por: Magbanua, Mark Jesus M., et al.
Publicado: (2015)

The 21-Gene Recurrence Score in Clinically High-Risk Lobular and Ductal Breast Cancer: A National Cancer Database Study
por: Abel, Mary Kathryn, et al.
Publicado: (2022)

Antitumor activity of zoledronic acid in primary breast cancer cells determined by the ATP tumor chemosensitivity assay
por: Fehm, Tanja, et al.
Publicado: (2012)

Zoledronic acid inhibits pulmonary metastasis dissemination in a preclinical model of Ewing’s sarcoma via inhibition of cell migration
por: Odri, Guillaume, et al.
Publicado: (2014)

Simultaneous Detection of Disseminated and Circulating Tumor Cells in Primary Breast Cancer Patients
por: Hartkopf, Andreas D., et al.
Publicado: (2016)

Significance of Micrometastases: Circulating Tumor Cells and Disseminated Tumor Cells in Early Breast Cancer
por: Oakman, Catherine, et al.
Publicado: (2010)

Tumor-infiltrating granulocytic cells promote cancer cell dissemination
por: Toh, B, et al.
Publicado: (2012)

Enrichment and detection of bone disseminated tumor cells in models of low tumor burden
por: Sowder, Miranda E., et al.
Publicado: (2018)

Circulating and disseminated tumor cells: harbingers or initiators of metastasis?
por: Dasgupta, Arko, et al.
Publicado: (2017)

The importance of circulating and disseminated tumor cells in pancreatic cancer
por: Hasanain, Alina, et al.
Publicado: (2019)

The Role of Circulating Tumor Cells in Ovarian Cancer Dissemination
por: Szczerba, Anna, et al.
Publicado: (2022)

Evaluation of the Pathways for Survivors Program to Address Breast Cancer Survivorship–Associated Distress: Survey Study
por: Umashankar, Saumya, et al.
Publicado: (2022)

Environmental control of invasiveness and metastatic dissemination of tumor cells: the role of tumor cell-host cell interactions
por: Calorini, Lido, et al.
Publicado: (2010)

Preventive effect of zoledronic acid on aromatase inhibitor-associated bone loss for postmenopausal breast cancer patients receiving adjuvant letrozole
por: Sun, Shengliang, et al.
Publicado: (2016)

Isolation and genomic analysis of circulating tumor cells from castration resistant metastatic prostate cancer
por: Magbanua, Mark Jesus M, et al.
Publicado: (2012)

Primary tumor-induced immunity eradicates disseminated tumor cells in syngeneic mouse model
por: Piranlioglu, Raziye, et al.
Publicado: (2019)

Primary tumor associated macrophages activate programs of invasion and dormancy in disseminating tumor cells
por: Borriello, Lucia, et al.
Publicado: (2022)

Senescent cancer cell vaccines induce cytotoxic T cell responses targeting primary tumors and disseminated tumor cells
por: Liu, Yue, et al.
Publicado: (2023)

Circulating tumor cell count during zoledronic acid treatment in men with metastatic prostate cancer: a pilot study
por: Ide, Hisamitsu, et al.
Publicado: (2014)

Zoledronic acid prevents the tumor-promoting effects of mesenchymal stem cells via MCP-1 dependent recruitment of macrophages
por: Jia, Xiao-Hua, et al.
Publicado: (2015)

Denosumab versus zoledronic acid in cases of surgically unsalvageable giant cell tumor of bone: A randomized clinical trial
por: Li, Shenglong, et al.
Publicado: (2019)

Denosumab versus zoledronic acid in cases of surgically unsalvageable giant cell tumor of bone: A randomized clinical trial
por: Yue, Jiaji, et al.
Publicado: (2022)

The Tumor-Educated-Macrophage Increase of Malignancy of Human Pancreatic Cancer Is Prevented by Zoledronic Acid
por: Hiroshima, Yukihiko, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_b5p5cobek122hjcillv92cj59r